Tristel Investor

Tristel proprietary chlorine dioxide (ClO₂): providing high-level disinfection in medical, pharmaceutical, veterinary and laboratory settings.


Invests into

Founded Date: 1998-01-01
Headquarters: Snailwell, United Kingdom
Investors Number: 2
Employee Number: 51-100
Industry: Manufacturing, Medical Device
Estimated Revenue: $10M to $50M
Number Of Exists: N/A
Funding Status: IPO
Investor Type: N/A
Investment Stage: Undisclosed